Publications

Show Filters

Searches all publications.

Search Fulltext

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-09-22
    E.g., 2018-09-22

Articles

173342 items
12:00 AM, Oct 31, 1994  |  BC Week In Review | Clinical News  |  Clinical Results

CDP571 data

Celltech (Slough, U.K.) reported Phase II results at the meeting of the American College of Rheumatology in Minneapolis, showing a 40 percent or more reduction in pain scores and reduction of 22-27 percent in swelling...
12:00 AM, Oct 17, 1994  |  BC Week In Review | Company News  |  Other News

Cephalon news

CEPH (West Chester, Penn.) received $12 million in loans from the state of Pennsylvania to help finance the company's $22 million facility expansion. Pennsylvania approved $10 million from its Sunny Day Fund and $2 million...
12:00 AM, Oct 17, 1994  |  BC Week In Review | Company News  |  Other News

Telios news

The San Diego company said it is searching for a merger partner or other strategic alliances or transactions. TLIO also said it is considering ways to increase revenue by subletting portions of its facilities and...
12:00 AM, Oct 17, 1994  |  BC Week In Review | Company News  |  Other News

Sequana other research news

The La Jolla company announced discovery of a gene locus narrowed to a small region on chromosome six that appears to be involved with a familial form of the reading disorder. Licensing of the discovery...
12:00 AM, Oct 17, 1994  |  BC Week In Review | Company News  |  Other News

GeneMedicine other research news

The Houston company received an $81,000 Phase I SBIR from the National Institute of Diabetes and Digestive and Kidney Diseases to develop synthetic muscle-specific gene expression systems to provide high levels of cell-specific gene expression...
12:00 AM, Oct 17, 1994  |  BC Week In Review | Company News  |  Other News

Ingenex other research news

The company announced it licensed the RB-94 gene, whose discovery was published in the Proceedings of the National Academy of Sciences. The new form of the RB gene, called RB-94, allows intracellular build-up of a...
12:00 AM, Oct 17, 1994  |  BC Week In Review | Company News  |  Deals

Paracelsian deal

PRLN signed a letter of intent to acquire Pacific Liaisons, a partnership that acquires and develops biologicals, natural products and foods from the Far East. Pacific Liaisons has an agreement with the Institute of Nutrition...
12:00 AM, Oct 17, 1994  |  BC Week In Review | Company News  |  Deals

Oncor deal

ONCR (Gaithersburg, Md.) recelved an exclusive worldwide Iicense from The Johns Hopkins University to a DNA-based test that identifies a clonal population of cells, which indicates the presence of cancer. The test first will be...
12:00 AM, Oct 17, 1994  |  BC Week In Review | Company News  |  Deals

Texas Biotech deal

TXB and L'Oreal's Synthélabo subsidiary (France) will co-develop and market compounds for vascular proliferation disease. Synthélabo invested $5 million for 1.4 million shares of the Houston company's common stock, and will pay a $3 million...
12:00 AM, Oct 17, 1994  |  BC Week In Review | Clinical News  |  Preclinical Results

Proteus International preclinical data

Proteus' joint venture company, Pharmapro, tested tissue sections from 169 cattle brains that had been diagnosed by current methods as either infected (in 83 cases) or non-infected. Proteus' test detected all infected cases and there...

Pages